# TG THERAPEUTICS, INC. (TGTX) FY2026 Q2 Balance Sheet

- Company: TG THERAPEUTICS, INC. (TGTX)
- Period: As of 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-05, accession number 0001437749-26-025955
- Page: https://plicit.ai/financials/tgtx/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/tgtx-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 1,639,629,000 US dollars
- **Current assets**: 1,145,687,000 US dollars
- **Non-current assets**: 493,942,000 US dollars
- **Liabilities**: 1,035,546,000 US dollars
- **Current liabilities**: 268,493,000 US dollars
- **Non-current liabilities**: 767,053,000 US dollars
- **Equity**: 604,083,000 US dollars
- **Cash and cash equivalents**: 482,575,000 US dollars
- **Accounts receivable, net**: 401,565,000 US dollars
- **Inventory**: 147,973,000 US dollars
- **Short-term investment securities**: 69,673,000 US dollars
- **Other current assets**: 43,901,000 US dollars
- **Deferred tax assets**: 343,428,000 US dollars
- **Non-current inventories**: 75,486,000 US dollars
- **Long-term investment securities**: 64,368,000 US dollars
- **Right of use assets**: 7,085,000 US dollars
- **Other noncurrent assets**: 2,211,000 US dollars
- **Restricted cash**: 1,364,000 US dollars
- **Accounts payable and accrued expenses**: 213,693,000 US dollars
- **Accrued compensation**: 35,205,000 US dollars
- **Deferred revenue - current portion**: 16,825,000 US dollars
- **Lease liability – current portion**: 1,913,000 US dollars
- **Other current liabilities**: 857,000 US dollars
- **Loan payable – non-current**: 745,387,000 US dollars
- **Deferred revenue, non-current portion**: 14,525,000 US dollars
- **Lease liability – non-current**: 7,141,000 US dollars
- **Additional paid-in capital**: 1,858,606,000 US dollars
- **Common stock, $0.001 par value per share (190,000,000 and 190,000,000 shares authorized, 159,949,330 and 158,849,596 shares issued, 153,077,784 and 155,305,953 shares outstanding at June 30, 2026 and December 31, 2025, respectively)**: 160,000 US dollars
- **Accumulated deficit**: negative 1,054,457,000 US dollars
- **Treasury stock, at cost, 6,871,546 and 3,543,643 shares at June 30, 2026 and December 31, 2025, respectively**: negative 200,226,000 US dollars
- **Gross equity (calculated)**: 1,858,766,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.